Clinical trials in other nations could be used to prove vaccine efficacy and safety according to international standards, the Food and Drug Administration (FDA) said yesterday, in response to accusations that a Medigen application to import a South Korean influenza vaccine was approved without full clinical trials in Taiwan.
The government flu shot program that began on Oct. 2 for the first time included a fourth quadrivalent flu vaccine from South Korean drugmaker GC Biopharma imported by Medigen.
Chinese Nationalist Party (KMT) Legislator Wang Hung-wei (王鴻薇) on Monday said that she had requested that the Ministry of Health and Welfare provide records of Medigen’s application, including clinical trial results, but was rejected on the grounds that they are “trade secrets.”
Photo: Su Chin-feng, Taipei Times
“The only trials conducted in Taiwan were on people aged 20 to 50, with other trials all conducted in South Korea,” she wrote on Facebook, asking how the public can trust vaccine safety if the trial data remain opaque.
At a news conference in Taipei yesterday, FDA Deputy Director Cheng Hwei-fang (陳惠芳) detailed the vaccine approval process used to approve all six available brands.
There is no requirement that clinical trials are conducted in Taiwan, only within Asia, Cheng said.
Taiwan is also more stringent than South Korea, which allows children six months and older to receive the GC Biopharma flu vaccine, compared with three years and older in Taiwan, she said.
When studied through an internationally recognized method of assessing “ethnic factors in the acceptability of foreign clinical data,” the South Korean data were determined to be insensitive to ethnic factors and could therefore be considered in the review process, she added.
Medigen also submitted information obtained from GC Biopharma’s clinical trials conducted in three age groups — three to 18, 19 and older, and 65 and older — Cheng said.
The other approved flu vaccines were similarly determined to be insensitive to ethnic factors and did not require local clinical trials, she said.
As for the refusal to publicize Medigen’s application, Cheng said the FDA has an obligation to maintain the confidentiality of trade secrets under Article 40-1 of the Pharmaceutical Affairs Act (藥事法), and that the data constitute “trade secrets” as defined in the Trade Secrets Act (營業秘密法).
Foreign tourists who purchase a seven-day Taiwan Pass are to get a second one free of charge as part of a government bid to boost tourism, the Tourism Administration said yesterday. A pair of Taiwan Passes is priced at NT$5,000 (US$156.44), an agency staff member said, adding that the passes can be used separately. The pass can be used in many of Taiwan’s major cities and to travel to several tourist resorts. It expires seven days after it is first used. The pass is a three-in-one package covering the high-speed rail system, mass rapid transport (MRT) services and the Taiwan Tourist Shuttle services,
Drinking a lot of water or milk would not help a person who has ingested terbufos, a toxic chemical that has been identified as the likely cause of three deaths, a health expert said yesterday. An 83-year-old woman surnamed Tseng (曾) and two others died this week after eating millet dumplings with snails that Tseng had made. Tseng died on Tuesday and others ate the leftovers when they went to her home to mourn her death that evening. Twelve people became ill after eating the dumplings following Tseng’s death. Their symptoms included vomiting and convulsions. Six were hospitalized, with two of them
DIVA-READY: The city’s deadline for the repairs is one day before pop star Jody Chiang is to perform at the Taipei Dome for the city’s Double Ten National Day celebrations The Taipei City Government has asked Farglory Group (遠雄集團) to repair serious water leaks in the Taipei Dome before Friday next week, Taipei Mayor Chiang Wan-an (蔣萬安) said yesterday, following complaints that many areas at the stadium were leaking during two baseball games over the weekend. The dome on Saturday and Sunday hosted two games in tribute to CTBC Brothers’ star Chou Szu-chi (周思齊) ahead of his retirement from the CPBL. The games each attracted about 40,000 people, filling the stadium to capacity. However, amid heavy rain, many people reported water leaking on some seats, at the entrance and exit areas, and the
BIG collection: The herbarium holds more than 560,000 specimens, from the Japanese colonial period to the present, including the Wulai azalea, which is now extinct in the wild The largest collection of plant specimens in Taiwan, the Taipei Botanical Garden’s herbarium, is celebrating its 100th anniversary with an exhibition that opened on Friday. The herbarium provides critical historical documents for botanists and is the first of its kind in Taiwan, Taiwan Forestry Research Institute director Tseng Yen-hsueh (曾彥學) said. It is housed in a two-story red brick building, which opened during 1924. At the time, it stored 30,000 plant specimens from almost 6,000 species, including Taiwanese plant samples collected by Tomitaro Makino, the “father of Japanese botany,” Tseng said. The herbarium collection has grown in the century since its